SEATTLE — Use of GLP-1 receptor agonists (GLP-1s) was associated with a reduction in fragility fractures among older women with type 2 diabetes (T2D) in a retrospective analysis of data from a global ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback